Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis
about
STAT1 is required for redifferentiation during Madin-Darby canine kidney tubulogenesisIFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activityScreening approaches to generating STAT inhibitors: Allowing the hits to identify the targetsTagging of genomic STAT3 and STAT1 with fluorescent proteins and insertion of a luciferase reporter in the cyclin D1 gene provides a modified A549 cell line to screen for selective STAT3 inhibitorsA novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNASTAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinomaThe PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular developmentS100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.Chromium(VI) stimulates Fyn to initiate innate immune gene induction in human airway epithelial cells.Angiogenesis-related factors in skeletal muscles of COPD patients: roles of angiopoietin-2.Mechanisms of vascular stability and the relationship to human diseaseIFN-γ and TNF-α synergize to inhibit CTGF expression in human lung endothelial cellsRisk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study.Sequence- and target-independent angiogenesis suppression by siRNA via TLR3ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio.Angiostatic effects of NK cell-derived IFN-γ counteracted by tumour cell Bcl-xL expression.EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degenerationPromyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant PathwayArteriovenous malformations and other vascular malformation syndromes.Signal transducer and activator of transcription 1 (STAT1) is essential for chromium silencing of gene induction in human airway epithelial cells.iTRAQ-Based Quantitative Proteomic Analysis of the Potentiated and Dormant Antler Stem Cells.IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.Distinctive responses of brain tumor cells to TLR2 ligands.9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling responseS100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 SignalingImmuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy.VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model.Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH.STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade.Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism.Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas.
P2860
Q24300702-6BB95880-D16D-4FFE-B7D8-BB18A327A2D0Q24651982-CA1BE22A-93AA-4DF2-BC24-89C72E299022Q27024482-69B36619-A0FD-4FF0-B8A9-C6BA268A63CCQ27311494-718C36DB-A286-4453-84AB-2571688A5440Q28472818-4CDAFB48-FDA8-4B1B-9728-75BC3B2911D5Q28538302-8FCD32A0-A516-4569-A725-D190AEECA39FQ28589178-6D3DBBBC-6DD6-41EF-93A8-66B7B61FF421Q33305131-265CE140-87A1-464D-B47C-294FCF328485Q33509884-D255C687-FA40-4660-835B-597B28D5B4A0Q33570322-1A3982DA-17E7-43F5-BD59-BDBAAB884746Q33799894-60922AEC-D2E1-4931-B81A-5E419F516F96Q33811222-802A73BD-087B-44C9-98AD-7A4EE5B0CC54Q34429022-8F24BF81-2A8F-4410-BDA9-E81173235C35Q34581222-CC6223ED-202D-4278-8101-6C21EA92929FQ34764750-52E46754-234A-4C33-8BE6-F1148D0EDDE8Q35042517-7CA8C47E-004A-4863-889F-A9A679EE97DDQ35061726-0BA07609-F254-470C-9D9B-BCA4E95921CCQ35227778-30EC27F3-3B87-4313-8478-983173830EA5Q35677921-BAB6223D-F8B4-4E1C-8F93-B9FF28290E0AQ35710032-8393670C-18AD-4738-A3A5-4547BB98256AQ36041894-F80E70AF-D509-413C-8B8C-81C1D67CE931Q36078727-62BB0976-0BFF-4B00-960A-597EC206645EQ36218965-1A7A4727-BBA4-4D3D-A456-5491B81EA602Q36554606-AE94267A-1337-493E-8C56-C327B7EAB038Q37227353-583BA220-8DC1-4938-81D1-70C0FF7BBBB8Q37465337-716840F2-C429-409F-B0E4-0FFA6DE38F72Q37532498-5FC299FA-B56D-4D58-BBB3-FD2ABC1AC8A0Q38915803-9CCF1F55-DFFD-4F6D-886F-127BB948D5A6Q39048288-2C0BAC1C-A467-4EC8-9F1A-660496783C8CQ40958940-981AB50D-1622-4BD5-B00A-2AC36D8E5704Q41192179-CDD63555-CAE8-4DD0-8F9E-C5B4EC28A96AQ42023344-4A394F22-88CF-4D79-A838-EE4B35DA31EDQ42511387-AD7C6CD1-6A06-4580-9A21-76F77A6091CAQ44479059-9C1BDB8E-F6EE-4CDB-8F61-D2A7474A69A1Q47227700-6A7F95B5-C6AA-454E-9BFA-B281E79E70E3Q47262034-137D17E9-C039-4413-9EE2-C5DB4B3ECA43Q50335895-7186653E-91B2-4B01-ABBD-EC6A52406A65Q52659954-617555CF-0D76-47AB-9AB3-95F682477364Q53156977-DA69E131-DF1B-42CE-A9CE-7F92353CEDACQ54516461-B220AF99-C71B-43C8-8B9B-92165A8C6746
P2860
Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Signal transducer and activato ...... tive regulator of angiogenesis
@ast
Signal transducer and activato ...... tive regulator of angiogenesis
@en
Signal transducer and activato ...... tive regulator of angiogenesis
@en-gb
Signal transducer and activato ...... tive regulator of angiogenesis
@nl
type
label
Signal transducer and activato ...... tive regulator of angiogenesis
@ast
Signal transducer and activato ...... tive regulator of angiogenesis
@en
Signal transducer and activato ...... tive regulator of angiogenesis
@en-gb
Signal transducer and activato ...... tive regulator of angiogenesis
@nl
prefLabel
Signal transducer and activato ...... tive regulator of angiogenesis
@ast
Signal transducer and activato ...... tive regulator of angiogenesis
@en
Signal transducer and activato ...... tive regulator of angiogenesis
@en-gb
Signal transducer and activato ...... tive regulator of angiogenesis
@nl
P2093
P3181
P1433
P1476
Signal transducer and activato ...... tive regulator of angiogenesis
@en
P2093
David A Frank
Rebecca A Lynch
Traci E Battle
P304
P3181
P356
10.1158/0008-5472.CAN-05-3612
P407
P577
2006-04-01T00:00:00Z